Biol Reprod
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mattsson, R.
Right arrow Articles by Van der Meide, P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mattsson, R.
Right arrow Articles by Van der Meide, P. H.
Agricola
Right arrow Articles by Mattsson, R.
Right arrow Articles by Van der Meide, P. H.

Biology of Reproduction, Vol 46, 1176-1186, Copyright © 1992 by Society for the Study of Reproduction


ARTICLES

In vivo treatment with interferon-gamma during early pregnancy in mice induces strong expression of major histocompatibility complex class I and II molecules in uterus and decidua but not in extra-embryonic tissues

R Mattsson, A Mattsson, R Holmdahl, A Scheynius and PH Van der Meide
Department of Zoophysiology, Uppsala, Sweden.

Allopregnant (NFR/N [Swiss-derived] H-2q females x 57/Bl H-2b males) and syngeneically pregnant (NFR/N x NFR/N) mice were subjected to daily injections (10(5) U/mouse/day, from Day 5.5 of gestation) of recombinant rat or mouse interferon-gamma (IFNg) in order to investigate its ability to induce extra-embryonic major histocompatibility complex (MHC) expression and antipaternal immune reactions if administered during the first part of the gestation period. In addition, a limited number of IFNg-treated embryo- transferred NFR/N mice carrying C57/B1 embryos (representing a complete allogenic pregnancy) were investigated. Mouse and rat IFNg caused the same type of histological and physiological changes, and most of the experiments were performed by using rat IFNg. Several IFNg-treated mice (irrespective of type of mating) showed a drop in weight and a high rate of resorptions at Day 12.5 of gestation. This interference with pregnancy appeared not to be caused by immunological reactions against the feto-placental unit (no leukocyte infiltration and no significant effect on serum levels of antipaternal antibodies in preimmunized allopregnant IFNg-treated mice). Immunohistochemical stainings of cryosectioned tissues at Day 9.5 of pregnancy revealed that IFNg treatment caused a strong induction of MHC class I and class II expression on most cells in the uterus and on several cells in the maternal decidua, while there was a complete absence of detectable MHC class I and class II expression in the extra-embryonic tissues. Characteristic for a Day 12.5 placenta of an IFNg-treated mouse (including embryo-transferred mice) was a strongly MHC class II-induced maternal decidua and a completely MHC class II-negative fetal placenta. The pattern of IFN-induced MHC class I expression was similar to that of class II, with the exception of class I expression on scattered cells within the basal zone. Thus, the present study provides immunohistological evidence that IFNg administered in vivo during the first part of gestation is not capable of inducing MHC expression on murine extra-embryonic cells despite an extremely high expression of MHC molecules on decidual cells in intimate contact with extra- embryonic tissues. It is likely that the resistance to IFNg-mediated induction of MHC expression on extra-embryonic cells is of basic importance for the protection of mammalian semi-allogeneic fetuses.


This article has been cited by other articles:


Home page
J. Immunol.Home page
M. M. Joyce, J. R. Burghardt, R. C. Burghardt, R. N. Hooper, F. W. Bazer, and G. A. Johnson
Uterine MHC Class I Molecules and {beta}2-Microglobulin Are Regulated by Progesterone and Conceptus Interferons during Pig Pregnancy
J. Immunol., August 15, 2008; 181(4): 2494 - 2505.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
M. Liljander, M.-A. Sallstrom, S. Andersson, P. Wernhoff, A. Andersson, R. Holmdahl, and R. Mattsson
Identification of Genetic Regions of Importance for Reproductive Performance in Female Mice
Genetics, June 1, 2006; 173(2): 901 - 909.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
Q.-H. Sun, J.-P. Peng, H.-F. Xia, Y. Yang, and M.-L. Liu
Effect on expression of RT1-A and RT1-DM molecules of treatment with interferon-{gamma} at the maternal--fetal interface of pregnant rats
Hum. Reprod., September 1, 2005; 20(9): 2639 - 2647.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
I. A. Khan and M. Moretto
Role of Gamma Interferon in Cellular Immune Response against Murine Encephalitozoon cuniculi Infection
Infect. Immun., April 1, 1999; 67(4): 1887 - 1893.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J. C. Cross, S. Lam, S. Yagel, and Z. Werb
Defective Induction of the Transcription Factor Interferon-StimulatedGene Factor-3 and Interferon {alpha} Insensitivity in Human Trophoblast Cells
Biol Reprod, February 1, 1999; 60(2): 312 - 321.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J.J. Ramsoondar, R.J. Christopherson, L.J. Guilbert, W.T. Dixon, A. Ghahary, S. Ellis, T.G. Wegmann, and J.A. Piedrahita
Lack of Class I Major Histocompatibility Antigens on Trophoblast of Periimplantation Blastocysts and Term Placenta in the Pig
Biol Reprod, February 1, 1999; 60(2): 387 - 397.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
J. Cross, Z Werb, and S. Fisher
Implantation and the placenta: key pieces of the development puzzle
Science, December 2, 1994; 266(5190): 1508 - 1518.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the Society for the Study of Reproduction.